Japan Tissue Engineering Co., Ltd. (TYO:7774)

Japan · Delayed Price · Currency is JPY

590.00

-21.00 (-3.44%)

Jun 24, 2026, 11:29 AM JST

-1.67% (1Y)

Market Cap	24.81B +5.2%
Revenue (ttm)	2.18B -11.1%
Net Income	-734.75M
EPS	-18.09
Shares Out	40.61M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,100
Open	608.00
Previous Close	611.00
Day's Range	589.00 - 612.00
52-Week Range	448.00 - 883.00
Beta	0.60
Analysts	n/a
Price Target	n/a
Earnings Date	Jul 30, 2026

About Japan Tissue Engineering

Japan Tissue Engineering Co., Ltd. engages in the regenerative medicine business in Japan. The company operates through Regenerative Medicine Product, Regenerative Medicine Contract, and Research and Development Support segments. It offers autologous cultured epidermis, cartilage, corneal epithelium, and oral mucosal epithelium to medical institutions for the purpose of medical treatment. The company also provides tissue-engineered medical products. In addition, it researches and develops human 3-dimensional cultured tissue models for use in th... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1999

Employees 204

Stock Exchange Tokyo Stock Exchange

Ticker Symbol 7774

Full Company Profile

Financial Performance

In fiscal year 2026, Japan Tissue Engineering's revenue was 2.18 billion, a decrease of -11.09% compared to the previous year's 2.46 billion. Losses were -734.75 million, 188.1% more than in 2025.

Financial Statements